期刊文献+

EMT相关蛋白CK、Vimentin、α-SMA在肺癌组织中的表达及意义 被引量:2

Expression and Clinical Significance of EMT Related Proteins CK,Vimentin andα-SM in Lung Adenocarcinoma Tissue
下载PDF
导出
摘要 【目的】探讨肺腺癌组织中上皮‐间叶转换(EMT)相关蛋白的表达及意义。【方法】采用免疫组化法检测100例肺腺癌及40例癌旁正常肺组织中的细胞角蛋白(CK)、波形蛋白(Vimentin)、α‐平滑肌肌动蛋白(α‐SMA)的表达,并分析其临床意义。【结果】肺腺癌组织中CK、Vimentin、α‐SMA阳性表达率分别为51.0%、60.0%、59.0%,与癌旁正常组织中各蛋白的表达率(分别为72.5%、25.0%、27.5%)比较均有显著性差异(P<0.05),CK、Vimentin、α‐SMA与分化程度相关,与年龄、性别、浸润深度、临床分期及远处转移不相关。【结论】CK与a‐SMA、Vimentin呈现负相关,分化程度降低,CK含量降低,α‐SMA、Vimentin呈现逐渐上升的趋势,提示肺癌恶变程度与EMT有关。 [Objective]To explore the expression and significance of epithelial mesenchymal transition (EMT) related proteins in lung adenocarcinoma tissues .[Methods]Immunohistochemical method was used to detect the epxression of CK protein ,vimentin protein and a‐smooth muscle actin protein(α‐SM) in 100 cases of lung adenocarcinoma and 40 cases of normal lung tissue adjacent to carcinoma .Clinical significance was ana‐lyzed .[Results] The positive rates of CK ,vimentin protein and α‐SM protein in lung adenocarcinoma tissues were 51 .0% ,60 .0% and 59 .0% respectively ,and those in normal tissues adjacent to carcinoma were 72 .5% , 25 .0% and 27 .5% respectively ,and there were signficant differences( P〈0 .05) .The expressions of CK ,vi‐mentin protein and α‐SM protein were related to tumor differentiation ,but not related to age ,sex ,invasive depth ,TNM stages and distant metastasis .[Conclusion]CK is negatively correlated to α‐SM and vimentin . When the differentiation degree is reduced ,the content of CK is decreased ,butα‐SM and vimentin are gradu‐ally raised ,which indicate that the canceration degree of lung cancer is associated with EMT .
出处 《医学临床研究》 CAS 2014年第10期1999-2001,共3页 Journal of Clinical Research
关键词 角蛋白质类/生物合成 波形蛋白/生物合成 肌动蛋白类/生物合成 腺癌/病理学 免疫组织化学 Keratins/BI Vimentin/BI Actins/BI Adenocarcinoma/PA Immunohistochemis-try
  • 相关文献

参考文献9

二级参考文献37

共引文献44

同被引文献30

  • 1邬兰,张永,曾宪涛.QUADAS-2在诊断准确性研究的质量评价工具中的应用[J].湖北医药学院学报,2013,32(3):201-208. 被引量:102
  • 2Zheng D, Haddadin S, Wang Y, et al. Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol, 2011, 4(6):575-586.
  • 3Boeri M, Verri C, Conte D, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A, 2011, 108(9):3713- 3718.
  • 4Hennessey PT, Sanford T, Choudhary A, et al. Serum microRNA biomarkers for detection of non-small cell lung cancer. PIoS One, 2012, 7(2):e32307.
  • 5VSsa U1, Vooder T, Kolde R, et al. Meta-analysis of microRNA expression in lung cancer. Int J Cancer, 2013, 132(12):2884-2893.
  • 6Wang Y, Gu J, Roth JA, et al. Pathway-based serum microRNAprofiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Res, 2013, 73(15):4801-4809.
  • 7Bianchi F, Nicassio F, Marzi M, et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med, 2011, 3(8):495-503.
  • 8Heegaard NH, Schetter AJ, Welsh JA, et al. Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer, 2012, 130(6): 1378-1386.
  • 9Gao W, Lu X, Liu L, et al. MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer. Cancer Biol Ther, 2012, 13(5):330-340.
  • 10李志,王中彬,刘长军.非小细胞肺癌组织中AQP1、VEGF的表达变化及临床意义[J].山东医药,2010,50(38):43-44. 被引量:2

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部